Annual report pursuant to Section 13 and 15(d)

Summary of Significant Accounting Policies (Details)

v3.6.0.2
Summary of Significant Accounting Policies (Details)
6 Months Ended 9 Months Ended 12 Months Ended
Jan. 01, 2018
Jan. 01, 2017
Jan. 01, 2016
Dec. 31, 2015
USD ($)
Jun. 30, 2016
USD ($)
Sep. 30, 2016
Dec. 31, 2016
USD ($)
Segment
Dec. 31, 2015
USD ($)
Dec. 31, 2014
USD ($)
Summary of Significant Accounting Policies [Line Items]                  
Inventory write-down             $ 0 $ 900,000  
Goodwill and intangible assets       $ 2,200,000,000     2,100,000,000 2,200,000,000  
Indefinite-lived intangible assets (excluding goodwill)       792,275,000     644,713,000 792,275,000  
Amortization of intangible assets             64,407,000 27,977,000 $ 10,919,000
Amortization expense in 2017             69,200,000    
Amortization expense in 2018             66,500,000    
Amortization expense in 2019             64,200,000    
Amortization expense in 2020             57,800,000    
Amortization expense in 2021             51,800,000    
Depreciation             $ 33,300,000 $ 14,200,000 $ 4,000,000
Federal statutory rate             35.00% 35.00% 35.00%
Income tax benefit on release of valuation allowance on deferred tax assets             $ 93,400,000    
Accrual related to uncertain tax positions included in income tax benefit             2,500,000    
Revenue from transfer of intellectual property and other             126,065,000 $ 81,853,000 $ 5,476,000
Deferred revenue       232,900,000     162,400,000 232,900,000  
Accounts receivable       219,043,000     256,552,000 219,043,000  
Allowance for doubtful accounts       25,168,000     36,268,000 25,168,000  
Provision for doubtful accounts             83,500,000 24,500,000  
Equity-based compensation expense for continuing operations             $ 42,693,000 26,074,000 14,779,000
Number of reportable segments | Segment             2    
Foreign currency transaction gain (loss)             $ 800,000 (2,400,000) (4,800,000)
Minimum                  
Summary of Significant Accounting Policies [Line Items]                  
Intangible assets, estimated useful lives             3 years    
Estimated tax exposure range             $ 0    
Maximum                  
Summary of Significant Accounting Policies [Line Items]                  
Intangible assets, estimated useful lives             20 years    
Estimated tax exposure range             $ 50,000,000    
Computer Software, Intangible Asset                  
Summary of Significant Accounting Policies [Line Items]                  
Property, plant and equipment, useful life             3 years    
Machinery, Medical and Other Equipment | Minimum                  
Summary of Significant Accounting Policies [Line Items]                  
Property, plant and equipment, useful life             5 years    
Machinery, Medical and Other Equipment | Maximum                  
Summary of Significant Accounting Policies [Line Items]                  
Property, plant and equipment, useful life             8 years    
Furniture and Fixtures | Minimum                  
Summary of Significant Accounting Policies [Line Items]                  
Property, plant and equipment, useful life             5 years    
Furniture and Fixtures | Maximum                  
Summary of Significant Accounting Policies [Line Items]                  
Property, plant and equipment, useful life             10 years    
Land, Buildings and Improvements | Minimum                  
Summary of Significant Accounting Policies [Line Items]                  
Property, plant and equipment, useful life             10 years    
Land, Buildings and Improvements | Maximum                  
Summary of Significant Accounting Policies [Line Items]                  
Property, plant and equipment, useful life             40 years    
Automobiles and Aircraft | Minimum                  
Summary of Significant Accounting Policies [Line Items]                  
Property, plant and equipment, useful life             3 years    
Automobiles and Aircraft | Maximum                  
Summary of Significant Accounting Policies [Line Items]                  
Property, plant and equipment, useful life             15 years    
Pfizer                  
Summary of Significant Accounting Policies [Line Items]                  
Revenue from transfer of intellectual property and other             $ 70,600,000 65,500,000  
Pfizer | Collaborative Arrangement, Product                  
Summary of Significant Accounting Policies [Line Items]                  
Deferred revenue             158,900,000    
TESARO | Collaborative Arrangement                  
Summary of Significant Accounting Policies [Line Items]                  
Milestone payment received               15,000,000  
TESARO | Collaborative Arrangement, Product                  
Summary of Significant Accounting Policies [Line Items]                  
Milestone revenue recognized             0 15,000,000 $ 5,000,000
VFMCRP Agreement                  
Summary of Significant Accounting Policies [Line Items]                  
Revenue from transfer of intellectual property and other             50,000,000.0    
Government Contracts Concentration Risk                  
Summary of Significant Accounting Policies [Line Items]                  
Accounts receivable       $ 26,100,000     $ 50,500,000 $ 26,100,000  
Sales Revenue, Net | Government Contracts Concentration Risk                  
Summary of Significant Accounting Policies [Line Items]                  
Percentage of revenue contributed by customer             16.00% 9.00%  
Self-Pay                  
Summary of Significant Accounting Policies [Line Items]                  
Percentage of revenue contributed by customer             7.30% 7.50%  
Scenario, Adjustment                  
Summary of Significant Accounting Policies [Line Items]                  
Indefinite-lived intangible assets (excluding goodwill)         $ (187,600,000)        
In Process Research and Development                  
Summary of Significant Accounting Policies [Line Items]                  
Intangible assets, estimated useful lives         12 years        
Internal Revenue Service (IRS)                  
Summary of Significant Accounting Policies [Line Items]                  
Federal statutory rate           35.00%      
Israel Tax Authority                  
Summary of Significant Accounting Policies [Line Items]                  
Federal statutory rate     25.00% 26.50%          
Israel Tax Authority | Scenario, Forecast                  
Summary of Significant Accounting Policies [Line Items]                  
Federal statutory rate 23.00%                
Accrued Expenses | Pfizer | Collaborative Arrangement, Product                  
Summary of Significant Accounting Policies [Line Items]                  
Deferred revenue             $ 70,600,000    
Finite-Lived Intangible Assets | Scenario, Adjustment                  
Summary of Significant Accounting Policies [Line Items]                  
Indefinite-lived intangible assets (excluding goodwill)         $ 187,600,000        
Rayaldee | Accrued Expenses                  
Summary of Significant Accounting Policies [Line Items]                  
Deferred revenue             $ 1,600,000    
Subsequent Event | Israel Tax Authority                  
Summary of Significant Accounting Policies [Line Items]                  
Federal statutory rate   24.00%